Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BSF EnterpriseBSFAF 3-Year ROIIC % is 211.35 as of Sep. 2025. The stock has 3 warning signs investors should review. Among 1,322 Biotechnology companies, BSF Enterprise ranks better than 84.57% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
BSF Enterprise's 3-Year ROIIC % for the quarter that ended in Sep. 2025 was 211.35%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for BSF Enterprise's 3-Year ROIIC % or its related term are showing as below:
BSFAF's 3-Year ROIIC % is ranked better than 84.57% of 1322
companies
in the Biotechnology industry
Industry Median: -4.82
vs BSFAF: 211.35
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
BSF Enterprise 3-Year ROIIC % Related Terms
BSF Enterprise 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for BSF Enterprise's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSFAF vs VRTX, REGN, ALNY: 3-Year ROIIC % Comparison
For the Biotechnology subindustry, BSF Enterprise's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BSF Enterprise 3-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BSF Enterprise's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where BSF Enterprise's 3-Year ROIIC % falls into.
BSF Enterprise's 3-Year ROIIC % for the quarter that ended in Sep. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -1.5023355 (Sep. 2025) - -0.852 (Sep. 2022) )
/
( 3.632 (Sep. 2025) - 3.235 (Sep. 2022) )
=
-0.6503355
/
0.397
=
-163.81%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
BSF Enterprise (BSFAF) has a 3-Year ROIIC % of 211.35 as of Sep. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on BSF Enterprise and its competitors. According to the industry distribution chart, BSF Enterprise ranks #204 out of 1322 companies in the Biotechnology industry, placing it in the top 15.4%.
Is BSF Enterprise's 3-Year ROIIC % too high?
BSF Enterprise's current 3-Year ROIIC % is 211.35. Based on the distribution chart, BSF Enterprise ranks #204 out of 1322 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does BSF Enterprise's 3-Year ROIIC % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BSF Enterprise ranks #204 out of 1322 companies for 3-Year ROIIC %. This places BSF Enterprise in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on BSF Enterprise and its competitors. BSF Enterprise's current 3-Year ROIIC % is 211.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BSF Enterprise stock overvalued right now?
BSF Enterprise (BSFAF) has a current 3-Year ROIIC % of 211.35. The current 3-Year ROIIC % is 211.35. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For BSF Enterprise (BSFAF), the current 3-Year ROIIC % is 211.35 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSFAF has been successfully added to your 
